Novanta Inc.

NasdaqGS:NOVT Stock Report

Market Cap: US$4.6b

Novanta Future Growth

Future criteria checks 3/6

Novanta is forecast to grow earnings and revenue by 33.9% and 6.3% per annum respectively while EPS is expected to grow by 29.3% per annum.

Key information

33.9%

Earnings growth rate

29.25%

EPS growth rate

Electronic earnings growth21.9%
Revenue growth rate6.3%
Future return on equityn/a
Analyst coverage

Low

Last updated20 Apr 2026

Recent future growth updates

Recent updates

NOVT: Future Earnings Power Will Rely On Executing Stronger Margins

Narrative update on Novanta The consensus analyst price target for Novanta has been raised by $12 to $150. Analysts cite updated models after Q4 results that indicate potential for stronger sales and margin performance.

NOVT: Future Earnings Power Will Rely On Accelerating Sales And Margins

Analysts have trimmed their fair value estimate for Novanta from $160 to $157, reflecting a slightly higher discount rate and a modestly lower future P/E assumption, while still pointing to expectations for improving sales and margins after recent model updates. Analyst Commentary Bullish Takeaways Bullish analysts see room for the shares to move toward their updated fair value range, supported by model revisions that assume improving sales trends and margin recovery after recent results.

NOVT: Future Earnings Power Will Rely On Accelerating Margins

Analysts have lifted their price target on Novanta to $150 from $138, citing updated Q4 models that suggest the company may be positioned for faster sales growth and margin expansion. Analyst Commentary Bullish Takeaways Bullish analysts point to the raised price target to $150 as a sign that updated Q4 assumptions support a higher valuation range for the shares.

NOVT: Future Earnings Power Will Rely On Accelerating Margins

Analysts have lifted their fair value estimate for Novanta to $160 from $154, supported by updated models that reflect expectations for accelerating sales and margins following recent Q4 results and a higher Street price target of $150 from $138. Analyst Commentary Recent commentary points to a more constructive view on Novanta following its Q4 results, with updated models feeding into a higher fair value framework and a Street price target of $150.

NOVT: Stable Outlook Will Rely On Steady Margins And Earnings Multiple

Narrative Update: Novanta Analyst Price Target The analyst price target for Novanta is unchanged at $154, as analysts keep their assumptions for fair value, discount rate, revenue growth, profit margin and future P/E essentially steady. Valuation Changes Fair Value: $154.00 remains effectively unchanged compared with the prior estimate of $154.

NOVT: Equity Units Offering Will Support Balance Sheet And Future Deals

Analysts have nudged their price target on Novanta slightly higher to reflect modest tweaks to the discount rate, revenue growth, profit margin, and future P/E assumptions, framing the move as fine tuning rather than a major reset in expectations. What's in the News Novanta plans to look for acquisitions and investments, signaling an interest in adding to its portfolio of businesses (Key Developments).

NOVT: Equity Units And Share Repurchases Will Support Balance Sheet And Future Deals

Analysts now keep their price target for Novanta effectively unchanged at about $154.00. They point to steady assumptions around discount rate, revenue growth, profit margin and future P/E as the key drivers of their view.

NOVT: Equity Units Offering Will Strengthen Balance Sheet And Support Future Deals

Analysts have maintained their fair value estimate for Novanta at approximately $154. They cite only marginal adjustments to the discount rate, long term revenue growth, profit margin assumptions, and future P/E, which do not materially change their overall outlook.

NOVT: New Equity Raise Will Strengthen Balance Sheet And Support Future Deals

Analysts have maintained their price target for Novanta at approximately $154 per share. This reflects a steady outlook, as incremental adjustments to discount rate assumptions and long term growth and profitability estimates are viewed as too minor to warrant a change in fair value.

NOVT: Expanded Equity Offering And Buybacks Will Drive Long Term Shareholder Value

Analysts have nudged their price target for Novanta slightly higher to align with its updated fair value of $154.00, reflecting modestly stronger confidence in the company’s steady growth and margin profile. What's in the News Novanta completed a $550 million composite tangible equity units offering, issuing 11 million units priced at $50 each, with a $1.375 discount per unit (Key Developments).

NOVT: Expanded Buyback Authorization Will Increase Shareholder Value Going Forward

Narrative Update on Novanta: Analyst Price Target Change Analysts have maintained Novanta's fair value estimate at $154. They cited improved profitability metrics, which offset slight adjustments in the discount rate and growth projections.

NOVT: Equity Buyback Expansion And Profit Margin Gains Will Drive Upside

Analysts have raised their fair value estimate for Novanta from $141.50 to $154.00 per share, citing expectations for stronger future revenue growth and improved profit margins, even though the discount rate is slightly higher. What's in the News Novanta Inc.

Novanta Inc. (NASDAQ:NOVT) Looks Just Right With A 30% Price Jump

Oct 28
Novanta Inc. (NASDAQ:NOVT) Looks Just Right With A 30% Price Jump

Is Now The Time To Look At Buying Novanta Inc. (NASDAQ:NOVT)?

Oct 07
Is Now The Time To Look At Buying Novanta Inc. (NASDAQ:NOVT)?

Novanta: The Solution To Elevated Expectations Is Lower Prices

Sep 29

Novanta's (NASDAQ:NOVT) Returns Have Hit A Wall

Sep 13
Novanta's (NASDAQ:NOVT) Returns Have Hit A Wall

Robotics And Healthcare Demand Will Expand Market Opportunities

Novanta’s fair value outlook remains unchanged, as both the discount rate and future P/E shifted only marginally, leaving the consensus analyst price target steady at $141.50. What's in the News Novanta projects third quarter 2025 GAAP revenue of $244 million to $247 million and full year 2025 GAAP revenue of $970 million to $985 million.

Novanta Inc.'s (NASDAQ:NOVT) Share Price Matching Investor Opinion

Aug 29
Novanta Inc.'s (NASDAQ:NOVT) Share Price Matching Investor Opinion

Are Novanta Inc. (NASDAQ:NOVT) Investors Paying Above The Intrinsic Value?

Jun 16
Are Novanta Inc. (NASDAQ:NOVT) Investors Paying Above The Intrinsic Value?

Returns At Novanta (NASDAQ:NOVT) Appear To Be Weighed Down

May 20
Returns At Novanta (NASDAQ:NOVT) Appear To Be Weighed Down

Here's Why Novanta (NASDAQ:NOVT) Can Manage Its Debt Responsibly

May 03
Here's Why Novanta (NASDAQ:NOVT) Can Manage Its Debt Responsibly

Should You Think About Buying Novanta Inc. (NASDAQ:NOVT) Now?

Apr 19
Should You Think About Buying Novanta Inc. (NASDAQ:NOVT) Now?

Novanta: A Trusted Yet Premium Technology Partner

Apr 06

Novanta Inc.'s (NASDAQ:NOVT) Stock Retreats 27% But Earnings Haven't Escaped The Attention Of Investors

Apr 05
Novanta Inc.'s (NASDAQ:NOVT) Stock Retreats 27% But Earnings Haven't Escaped The Attention Of Investors

There May Be Some Bright Spots In Novanta's (NASDAQ:NOVT) Earnings

Mar 05
There May Be Some Bright Spots In Novanta's (NASDAQ:NOVT) Earnings

Novanta (NASDAQ:NOVT) Has Some Way To Go To Become A Multi-Bagger

Feb 09
Novanta (NASDAQ:NOVT) Has Some Way To Go To Become A Multi-Bagger

Is Novanta (NASDAQ:NOVT) A Risky Investment?

Jan 24
Is Novanta (NASDAQ:NOVT) A Risky Investment?

Should You Investigate Novanta Inc. (NASDAQ:NOVT) At US$151?

Jan 07
Should You Investigate Novanta Inc. (NASDAQ:NOVT) At US$151?

Novanta: Delayed Recovery And Prolonged Struggles Ahead, Downgrade To Sell

Jan 01

Novanta Inc.'s (NASDAQ:NOVT) Business Is Yet to Catch Up With Its Share Price

Dec 21
Novanta Inc.'s (NASDAQ:NOVT) Business Is Yet to Catch Up With Its Share Price

Novanta (NASDAQ:NOVT) May Have Issues Allocating Its Capital

Oct 15
Novanta (NASDAQ:NOVT) May Have Issues Allocating Its Capital

What You Can Learn From Novanta Inc.'s (NASDAQ:NOVT) P/S

Sep 12
What You Can Learn From Novanta Inc.'s (NASDAQ:NOVT) P/S

Novanta Inc.: Overpriced In A Weak Demand Market. Here's Why It's A Hold

Sep 02
User avatar

Innovative Medical Devices And Tactical Acquisitions Poised To Accelerate Company Growth

Focusing on medical devices with new products might significantly boost future revenue through innovation, aiming for notable revenue from new launches by 2025.

Is It Too Late To Consider Buying Novanta Inc. (NASDAQ:NOVT)?

Aug 24
Is It Too Late To Consider Buying Novanta Inc. (NASDAQ:NOVT)?

Novanta Inc.'s (NASDAQ:NOVT) Intrinsic Value Is Potentially 21% Below Its Share Price

Aug 02
Novanta Inc.'s (NASDAQ:NOVT) Intrinsic Value Is Potentially 21% Below Its Share Price

Novanta (NASDAQ:NOVT) Might Be Having Difficulty Using Its Capital Effectively

Jun 22
Novanta (NASDAQ:NOVT) Might Be Having Difficulty Using Its Capital Effectively

Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?

May 30
Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?

Investors Still Waiting For A Pull Back In Novanta Inc. (NASDAQ:NOVT)

May 08
Investors Still Waiting For A Pull Back In Novanta Inc. (NASDAQ:NOVT)

Earnings and Revenue Growth Forecasts

NasdaqGS:NOVT - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20271,1131111812013
12/31/20261,045891591793
12/31/2025981544864N/A
9/26/202596053103117N/A
6/27/202595761118131N/A
3/28/202595271142157N/A
12/31/202494964141159N/A
9/27/202492360115136N/A
6/28/202490062133158N/A
3/29/202489369120143N/A
12/31/202388273100120N/A
9/29/202388876104122N/A
6/30/2023890777792N/A
3/31/2023876737390N/A
12/31/2022861747091N/A
9/30/2022841735779N/A
7/1/2022796645378N/A
4/1/2022748585883N/A
12/31/2021707507295N/A
10/1/20216554992112N/A
7/2/202162144124141N/A
4/2/202159844132146N/A
12/31/202059145127140N/A
10/2/202060341117129N/A
7/3/2020614428294N/A
4/3/2020624406276N/A
12/31/2019626415363N/A
9/27/201962343N/A50N/A
6/28/201962956N/A70N/A
3/29/201962557N/A75N/A
12/31/201861451N/A90N/A
9/28/201860539N/A90N/A
6/29/201859118N/A74N/A
3/30/201855912N/A71N/A
12/31/201752140N/A63N/A
9/29/201747348N/A54N/A
6/30/201742555N/A54N/A
3/31/201740354N/A52N/A
12/31/201638522N/A48N/A
9/30/201637620N/A43N/A
7/1/201637119N/A43N/A
4/1/201636934N/A36N/A
12/31/201537436N/A33N/A
10/2/20153771N/A34N/A
7/3/20153800N/A37N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: NOVT's forecast earnings growth (33.9% per year) is above the savings rate (3.4%).

Earnings vs Market: NOVT's earnings (33.9% per year) are forecast to grow faster than the US market (16% per year).

High Growth Earnings: NOVT's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: NOVT's revenue (6.3% per year) is forecast to grow slower than the US market (11.2% per year).

High Growth Revenue: NOVT's revenue (6.3% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if NOVT's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/04 12:54
End of Day Share Price 2026/05/04 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Novanta Inc. is covered by 8 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Robert MasonBaird
Quinn FredricksonBaird
Andrew BuscagliaBerenberg